Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

CancerVax licenses rights to SAI product candidates targeting EGFR

July 20, 2004

Small molecule VEGF antagonist inhibits tumor growth in vivo

July 20, 2004

Phosphotidylinositol 3-kinase inhibitors described by Chiron

July 19, 2004

Lilly claims TGF-beta signal transduction inhibitors

July 19, 2004

Phase I trial for new formulation of 17-AAG in multiple myeloma

July 19, 2004

Antitumor sulfonamides claimed by Lilly

July 16, 2004

Elan to produce reformulated Panzem for EntreMed oncology program

July 16, 2004

Fourth phase II study of PI-88 launches

July 16, 2004

Encouraging results for MF-5232 for mucositis

July 16, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...